MedTrace Logo

PROMOTE: The Effect of a Six Week Prebiotic Supplementation on Wellbeing of Young Adults.

NCT06566157 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-05-13

No results posted yet for this study

Summary

The study will investigate whether taking a prebiotic for six weeks helps to reduce morning cortisol levels in healthy young adults with mild to moderate stress compared to a placebo. Individuals should continue with their usual lifestyle during the study. Other factors of wellbeing will also be assessed.

Conditions

Interventions

DIETARY_SUPPLEMENT

Prebiotic

WellBiome® prebiotic complex: Inulin 67%, XOS 27%, Magnesium Chloride (MgCl2) 9.8 %

DIETARY_SUPPLEMENT

Maltodextrin (Corn)

Placebo

Sponsors & Collaborators

  • OptiBiotix Health Plc

    collaborator UNKNOWN

  • University of Southampton

    lead OTHER

Principal Investigators

  • Jonathan R Swann, Professor · University of Southampton, Faculty of Medicine - Human Development and Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-06
Primary Completion
2025-09-16
Completion
2026-09-16

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06566157 on ClinicalTrials.gov